BR112018068803A2 - método para purificação de proteína - Google Patents

método para purificação de proteína

Info

Publication number
BR112018068803A2
BR112018068803A2 BR112018068803A BR112018068803A BR112018068803A2 BR 112018068803 A2 BR112018068803 A2 BR 112018068803A2 BR 112018068803 A BR112018068803 A BR 112018068803A BR 112018068803 A BR112018068803 A BR 112018068803A BR 112018068803 A2 BR112018068803 A2 BR 112018068803A2
Authority
BR
Brazil
Prior art keywords
protein purification
antibodies
fragment
manufacture
provides
Prior art date
Application number
BR112018068803A
Other languages
English (en)
Inventor
Symmons Jonathan
Jones Richard
Hocking Saskia
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58461345&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112018068803(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of BR112018068803A2 publication Critical patent/BR112018068803A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265—Adsorption chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

a presente invenção fornece um método para a fabricação de anticorpos ou um fragmento do mesmo com níveis reduzidos de impurezas relacionadas com a redução do anticorpo.
BR112018068803A 2016-04-01 2017-03-31 método para purificação de proteína BR112018068803A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201605562 2016-04-01
PCT/EP2017/057685 WO2017167960A1 (en) 2016-04-01 2017-03-31 Method for protein purification

Publications (1)

Publication Number Publication Date
BR112018068803A2 true BR112018068803A2 (pt) 2019-01-22

Family

ID=58461345

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068803A BR112018068803A2 (pt) 2016-04-01 2017-03-31 método para purificação de proteína

Country Status (18)

Country Link
US (1) US11014962B2 (pt)
EP (1) EP3436173A1 (pt)
JP (2) JP7012023B2 (pt)
KR (1) KR102413808B1 (pt)
CN (1) CN108883345B (pt)
AU (1) AU2017242900B2 (pt)
BR (1) BR112018068803A2 (pt)
CA (1) CA3016847C (pt)
CL (1) CL2018002689A1 (pt)
CO (1) CO2018010286A2 (pt)
EA (1) EA201892231A1 (pt)
HK (1) HK1257713A1 (pt)
IL (1) IL261560B (pt)
MX (1) MX2018011435A (pt)
MY (1) MY197993A (pt)
RU (1) RU2737539C2 (pt)
SG (1) SG11201807676UA (pt)
WO (1) WO2017167960A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023136820A1 (en) * 2022-01-13 2023-07-20 Bayer Healthcare Llc Improved antibody manufacture
WO2024110444A1 (en) 2022-11-21 2024-05-30 Chreto Aps Method for purification of a target product using affinity purification technology

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659795A (en) * 1979-10-22 1981-05-23 Kanegafuchi Chem Ind Co Ltd Purification of nicotinic acid amide adenine dinucleotide
JP5808249B2 (ja) * 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインａアフィニティークロマトグラフィーを用いる抗体の単離および精製
WO2013028330A2 (en) * 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
CN104105703A (zh) * 2012-03-26 2014-10-15 Emd密理博公司 带电的氟碳化合物组合物在纯化生物分子的方法中的用途
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9650411B2 (en) * 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
AU2014234962C1 (en) * 2013-03-21 2019-01-17 Evonik Operations Gmbh Purification of triple helical proteins
US9910041B2 (en) 2013-07-12 2018-03-06 Emd Millipore Corporation Method of determining virus removal from a sample containing a target protein using activated carbon
WO2015005960A1 (en) * 2013-07-12 2015-01-15 Emd Millipore Corporation Removal of fragments from a sample containing a target protein using activated carbon
CN104546715B (zh) 2014-12-22 2018-01-16 蓝佳堂生物医药（福建）有限公司 一种用于上呼吸道感染的复合抗体口腔喷剂及其制备方法

Also Published As

Publication number Publication date
CL2018002689A1 (es) 2018-11-23
SG11201807676UA (en) 2018-10-30
US20190153028A1 (en) 2019-05-23
RU2018138445A3 (pt) 2020-07-07
IL261560B (en) 2021-06-30
HK1257713A1 (zh) 2019-10-25
CO2018010286A2 (es) 2018-10-31
EA201892231A1 (ru) 2019-03-29
CN108883345A (zh) 2018-11-23
IL261560A (en) 2018-10-31
CA3016847A1 (en) 2017-10-05
EP3436173A1 (en) 2019-02-06
RU2018138445A (ru) 2020-05-12
RU2737539C2 (ru) 2020-12-01
CA3016847C (en) 2023-12-19
JP7012023B2 (ja) 2022-01-27
KR102413808B1 (ko) 2022-06-29
JP2022036993A (ja) 2022-03-08
CN108883345B (zh) 2022-09-13
MY197993A (en) 2023-07-25
KR20180131599A (ko) 2018-12-10
AU2017242900A1 (en) 2018-10-04
US11014962B2 (en) 2021-05-25
MX2018011435A (es) 2019-01-10
JP2019512255A (ja) 2019-05-16
WO2017167960A1 (en) 2017-10-05
AU2017242900B2 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
PH12016501212A1 (en) Human anti-il-33 neutralizing monoclonal antibody
EA201790984A1 (ru) Анти-cd79b антитела и способы их применения
GT201700284A (es) Terapias de combinación para enfermedades malignas hematológicas con anticuerpos anti-cd38 e inhibidores de survivina
BR112018010360A2 (pt) fragmentos fab de fator de complemento anti-c1q e utilizações dos mesmos
CL2019000082A1 (es) Anticuerpos específicos para la tau hiperfosforilada y sus métodos de uso.
CR20170131A (es) Anticuerpos anti-her2 e inmunoconjugados
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
BR112016019866A2 (pt) terapias de combinação com anticorpos anti-cd38
MX2019011423A (es) Metodos de tratamiento de enfermedades neurodegenerativas.
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
CR20170026A (es) Anticuerpos anti-tau humanizados
BR112016019871A2 (pt) anticorpos anti-cd38 para o tratamento de leucemia linfoblástica aguda
BR112013020500A2 (pt) anticorpo isolado, recombinante ou purificado
EP3294766C0 (en) HUMANIZED ANTIBODY OR FRAGMENT THEREOF SPECIFIC FOR CD3
BR112016002845A2 (pt) composições e métodos para tratar condições associadas ao complemento
MX2020004674A (es) Anticuerpos contra alfa-sinucleina y usos de los mismos.
UY36942A (es) Proteínas de unión a antígeno que activan el receptor de leptina
BR112019004990A2 (pt) anticorpo que se liga especificamente a il-17a e fragmento funcional do mesmo
BR112017022073A2 (pt) método para purificação de proteína
EA201890340A1 (ru) Моноклональное антитело-ингибитор фактора xiia
ZA201903896B (en) Novel anti-human muc1 antibody fab fragment
CU24556B1 (es) Anticuerpos anti-basigin humanizados
BR112018072066A2 (pt) moléculas de ligação específicas para fcgamariia e uso das mesmas
CL2018000092A1 (es) Anticuerpos que se unen a la sortilina e inhiben la union de progranulina.
EA201890739A1 (ru) Анти-s100a8 для лечения лейкемии

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]